In this issue:
Childhood infections and development of psoriasis vulgaris
Sleep patterns and the risk of psoriatic disease
Routine latent tuberculosis testing with IL-17 or IL-23 inhibitors
PD-L1 expression in psoriatic skin
Systemic immune-inflammation index dynamics with methotrexate
Cardiovascular-kidney-metabolic health and risk of psoriasis
Methotrexate and cardiovascular outcomes in psoriasis
Features associated with biologic therapy switch in psoriasis
Age-related variations and predictors of remission in paediatric psoriasis
Coronary artery calcification and acute coronary syndrome risk
Please login below to download this issue (PDF)